IP Library Granted Patent US 10,758,409
Granted Patent B2
US 10,758,409 · App. 15/636,532 · Granted Sep 1, 2020

Apparatus and method for treating eye diseases

Inventors: Jeff Franco (Plano, TX); Michael Calhoun (Lighthouse Point, FL)
Assignee: J.D. Franco & Co., LLC
A61F9/007A61F2/07A61F2/856A61F2/90A61F2/95A61F2/966A61F9/0017A61F2002/061A61F2002/821A61F2210/0004A61F2250/0039A61F2250/0067A61F2250/0098
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,758,409
App. No.
15/636,532
Granted
Sep 1, 2020
Kind
B2
Abstract

A method, device, or system for treating eye disorders or conditions, comprising restoring or increasing blood flow or blood flow rate in an artery that supplies blood to or in the eye, thereby increasing the amount of oxygen that reaches the eye or a portion thereof.

Claims (34)

1. A method for treating an eye disease, condition, or disorder in a diseased blood vessel of an eye of a subject, the method comprising:

increasing an amount of oxygen available to the diseased blood vessel of the eye, the increasing the amount of oxygen comprising:

inserting a stent into an artery of the subject from which the diseased blood vessel branches, the stent having a side opening between a distal end and a proximal end thereof;

positioning the side opening of the stent over an ostium between the artery and the diseased blood vessel of the subject; and

deploying the stent.

2. The method of claim 1 , wherein a diameter of the stent is from 2.5 mm to 5.5 mm, and an overall length of the stent is from 15 mm to 40 mm.

3. The method of claim 1 , wherein the stent has a tapered diameter.

4. The method of claim 1 , wherein the stent is self-expanding.

5. The method of claim 1 , wherein the stent comprises one or a combination of Nitinol, chromium cobalt, stainless steel, polymer, or a bioresorbable material.

6. The method of claim 1 , further comprising:

removing material from the diseased blood vessel via an atherectomy procedure.

7. The method of claim 1 , wherein deploying the stent comprises deploying a distal portion of the stent prior to the positioning the side opening step, and deploying a proximal portion of the stent after the positioning the side opening step.

8. The method of claim 1 , wherein the artery is an internal carotid artery and the diseased blood vessel is an ophthalmic artery of the subject.

9. The method of claim 8 , wherein deploying the stent includes increasing a diameter of the internal carotid artery.

10. The method of claim 1 , further comprising delivering one or more pharmaceutical agents via the stent.

11. The method of claim 1 , wherein positioning the side opening of the stent over the ostium includes observing if blood flow between the artery and the diseased blood vessel via the ostium is maintained or initiated.

12. A method of treating an eye condition of an eye of a subject, the method comprising:

advancing a stent within an internal carotid artery of the subject to a delivery site, the stent including a plurality of struts and a side-wall opening positioned between a distal end of the stent and a proximal end of the stent;

deploying the distal end of the stent distally of an ostium between the internal carotid artery and an ophthalmic artery of the subject;

after deploying the distal end of the stent, manipulating the stent so that the side-wall opening of the stent is aligned with the ostium; and

after the manipulating the stent, deploying the proximal end of the stent proximally of the ostium.

13. The method of claim 12 , wherein a diameter of the stent is from 2.5 mm to 5.5 mm, and an overall length of the stent is from 15 mm to 40 mm.

14. The method of claim 12 , wherein the stent has a tapered diameter.

15. The method of claim 12 , wherein the stent is self-expanding.

16. The method of claim 12 , wherein the stent comprises one or a combination of Nitinol, chromium cobalt, stainless steel, polymer, or a bioresorbable material.

17. The method of claim 12 , wherein the manipulating the stent includes observing if blood flow between the internal carotid artery and the ophthalmic artery via the ostium is maintained or initiated.

18. The method of claim 12 , wherein a central longitudinal axis extending through the side-wall opening is transverse to a central longitudinal axis extending between the proximal end and the distal end of the stent.

19. The method of claim 12 , further including deploying a filter distal of the stent.

20. A method of treating an eye condition of an eye of a subject, the method comprising:

advancing a stent within an internal carotid artery of the subject to a delivery site, the stent including a plurality of struts and a side-wall opening positioned between a distal end of the stent and a proximal end of the stent, wherein a central longitudinal axis extending through the side-wall opening is transverse to a central longitudinal axis extending between the proximal end and the distal end of the stent;

deploying the distal end of the stent distally of an ostium between the internal carotid artery and an ophthalmic artery of the subject;

after deploying the distal end of the stent, manipulating the stent so that the side-wall opening of the stent is aligned with the ostium, wherein the manipulating the stent includes adjusting a location of the distal end of the stent;

observing if blood flow between the internal carotid artery and the ophthalmic artery via the ostium is maintained or initiated; and

after the manipulating the stent, deploying the proximal end of the stent proximally of the ostium.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2020
From: OCUDYNE, INC.
To: J.D. FRANCO & CO., LLC
Reel/Frame 053305/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: CALHOUN, MICHAEL
To: OCUDYNE, INC.
Reel/Frame 048594/0742 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: FRANCO, JEFF
To: OCUDYNE, INC.
Reel/Frame 048594/0752 →
Continuity (7)
Continuation PCTUS2015067939 · Dec 29, 2015
Provisional Application 62148701 · Apr 16, 2015
Provisional Application 62137789 · Mar 24, 2015
Provisional Application 62097552 · Dec 29, 2014
Provisional Application 62097554 · Dec 29, 2014
Provisional Application 62097556 · Dec 29, 2014
Related Publication 20180140460A1 · May 24, 2018
Cited By (1)
US 12,589,025